Selected research
Market Outlook & Growth Opportunities
Global Digital COPD Management Market Outlook and Growth Opportunities 2026
Market perspective
The global Digital COPD Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Digital COPD Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Digital COPD Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Digital COPD Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Digital COPD Management market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Digital COPD Management market include Teva Digital Health, AstraZeneca Digital Health, GSK Digital Health, Boehringer Ingelheim Digital Health, Huma Therapeutics, Biofourmis, Kaia Health, Ada Health and Current Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Digital COPD Management market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Digital COPD Management and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Digital COPD Management revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital COPD Management market.
Digital COPD Management Segment by Company
Teva Digital Health
AstraZeneca Digital Health
GSK Digital Health
Boehringer Ingelheim Digital Health
Huma Therapeutics
Biofourmis
Kaia Health
Ada Health
Current Health
Wellinks
Sensviv
ResMed Inc
Philips Respironics
Propeller Health
Digital COPD Management Segment by Type
Symptom Monitoring
Lung Function Management
Acute Exacerbation Prediction
Medication Adherence Management
Others
Digital COPD Management Segment by Application
Hospital Respiratory Department Management
Home Health Self-Management
Insurance-Based Health Management
Telemedicine
Digital COPD Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Digital COPD Management status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Digital COPD Management key companies, revenue, market share, and recent developments.
3. To split the Digital COPD Management breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Digital COPD Management market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Digital COPD Management significant trends, drivers, influence factors in global and regions.
6. To analyze Digital COPD Management competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital COPD Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital COPD Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital COPD Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital COPD Management industry.
Chapter 3: Detailed analysis of Digital COPD Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Digital COPD Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Digital COPD Management in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Digital COPD Management Industry Trends
Table 2. Digital COPD Management Industry Drivers
Table 3. Digital COPD Management Industry Opportunities and Challenges
Table 4. Digital COPD Management Industry Restraints
Table 5. Global Digital COPD Management Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Digital COPD Management Revenue Share by Company (2021-2026)
Table 7. Global Digital COPD Management Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Digital COPD Management Key Company Manufacturing Base & Headquarters
Table 9. Global Digital COPD Management Company, Product Type & Application
Table 10. Global Digital COPD Management Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Digital COPD Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Symptom Monitoring
Table 15. Significant Companies of Lung Function Management
Table 16. Significant Companies of Acute Exacerbation Prediction
Table 17. Significant Companies of Medication Adherence Management
Table 18. Significant Companies of Others
Table 19. Global Digital COPD Management Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 20. Global Digital COPD Management Sales Value by Type (2021-2026) & (US$ Million)
Table 21. Global Digital COPD Management Sales Value by Type (2027-2032) & (US$ Million)
Table 22. Global Digital COPD Management Sales Value Share by Type (2021-2026)
Table 23. Global Digital COPD Management Sales Value Share by Type (2027-2032)
Table 24. Significant Companies of Hospital Respiratory Department Management
Table 25. Significant Companies of Home Health Self-Management
Table 26. Significant Companies of Insurance-Based Health Management
Table 27. Significant Companies of Telemedicine
Table 28. Global Digital COPD Management Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 29. Global Digital COPD Management Sales Value by Application (2021-2026) & (US$ Million)
Table 30. Global Digital COPD Management Sales Value by Application (2027-2032) & (US$ Million)
Table 31. Global Digital COPD Management Sales Value Share by Application (2021-2026)
Table 32. Global Digital COPD Management Sales Value Share by Application (2027-2032)
Table 33. Global Digital COPD Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Global Digital COPD Management Sales Value by Region (2021-2026) & (US$ Million)
Table 35. Global Digital COPD Management Sales Value Share by Region (2021-2026)
Table 36. Global Digital COPD Management Sales Value by Region (2027-2032) & (US$ Million)
Table 37. Global Digital COPD Management Sales Value Share by Region (2027-2032)
Table 38. Global Digital COPD Management Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 39. Global Digital COPD Management Sales Value by Country (2021-2026) & (US$ Million)
Table 40. Global Digital COPD Management Sales Value Market Share by Country (2021-2026)
Table 41. Global Digital COPD Management Sales Value by Country (2027-2032) & (US$ Million)
Table 42. Global Digital COPD Management Sales Value Market Share by Country (2027-2032)
Table 43. Teva Digital Health Company Information
Table 44. Teva Digital Health Business Overview
Table 45. Teva Digital Health Digital COPD Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 46. Teva Digital Health Digital COPD Management Product Portfolio
Table 47. Teva Digital Health Recent Development
Table 48. AstraZeneca Digital Health Company Information
Table 49. AstraZeneca Digital Health Business Overview
Table 50. AstraZeneca Digital Health Digital COPD Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 51. AstraZeneca Digital Health Digital COPD Management Product Portfolio
Table 52. AstraZeneca Digital Health Recent Development
Table 53. GSK Digital Health Company Information
Table 54. GSK Digital Health Business Overview
Table 55. GSK Digital Health Digital COPD Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. GSK Digital Health Digital COPD Management Product Portfolio
Table 57. GSK Digital Health Recent Development
Table 58. Boehringer Ingelheim Digital Health Company Information
Table 59. Boehringer Ingelheim Digital Health Business Overview
Table 60. Boehringer Ingelheim Digital Health Digital COPD Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 61. Boehringer Ingelheim Digital Health Digital COPD Management Product Portfolio
Table 62. Boehringer Ingelheim Digital Health Recent Development
Table 63. Huma Therapeutics Company Information
Table 64. Huma Therapeutics Business Overview
Table 65. Huma Therapeutics Digital COPD Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 66. Huma Therapeutics Digital COPD Management Product Portfolio
Table 67. Huma Therapeutics Recent Development
Table 68. Biofourmis Company Information
Table 69. Biofourmis Business Overview
Table 70. Biofourmis Digital COPD Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. Biofourmis Digital COPD Management Product Portfolio
Table 72. Biofourmis Recent Development
Table 73. Kaia Health Company Information
Table 74. Kaia Health Business Overview
Table 75. Kaia Health Digital COPD Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 76. Kaia Health Digital COPD Management Product Portfolio
Table 77. Kaia Health Recent Development
Table 78. Ada Health Company Information
Table 79. Ada Health Business Overview
Table 80. Ada Health Digital COPD Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 81. Ada Health Digital COPD Management Product Portfolio
Table 82. Ada Health Recent Development
Table 83. Current Health Company Information
Table 84. Current Health Business Overview
Table 85. Current Health Digital COPD Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. Current Health Digital COPD Management Product Portfolio
Table 87. Current Health Recent Development
Table 88. Wellinks Company Information
Table 89. Wellinks Business Overview
Table 90. Wellinks Digital COPD Management Revenue (US$ Million) and Gross Margin (2021-2026)
Table 91. Wellinks Digital COPD Management Product Portfolio
Table 92. Wellinks Recent Development
Table 93. Sensviv Company Information
Table 94. Sensviv Business Overview
Table 95. Sensviv Digital COPD Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Sensviv Digital COPD Management Product Portfolio
Table 97. Sensviv Recent Development
Table 98. ResMed Inc Company Information
Table 99. ResMed Inc Business Overview
Table 100. ResMed Inc Digital COPD Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. ResMed Inc Digital COPD Management Product Portfolio
Table 102. ResMed Inc Recent Development
Table 103. Philips Respironics Company Information
Table 104. Philips Respironics Business Overview
Table 105. Philips Respironics Digital COPD Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 106. Philips Respironics Digital COPD Management Product Portfolio
Table 107. Philips Respironics Recent Development
Table 108. Propeller Health Company Information
Table 109. Propeller Health Business Overview
Table 110. Propeller Health Digital COPD Management Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 111. Propeller Health Digital COPD Management Product Portfolio
Table 112. Propeller Health Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Authors List of This Report
Table 115. Secondary Sources
Table 116. Primary Sources
List of Figures
Figure 1. Digital COPD Management Product Image
Figure 2. Global Digital COPD Management Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Digital COPD Management Market Size (2021-2032) & (US$ Million)
Figure 4. Global Digital COPD Management Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Symptom Monitoring Image
Figure 8. Lung Function Management Image
Figure 9. Acute Exacerbation Prediction Image
Figure 10. Medication Adherence Management Image
Figure 11. Others Image
Figure 12. Global Digital COPD Management Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 13. Global Digital COPD Management Sales Value Share 2021 VS 2025 VS 2032
Figure 14. Global Digital COPD Management Sales Value Share by Type (2021-2032)
Figure 15. Hospital Respiratory Department Management Image
Figure 16. Home Health Self-Management Image
Figure 17. Insurance-Based Health Management Image
Figure 18. Telemedicine Image
Figure 19. Global Digital COPD Management Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 20. Global Digital COPD Management Sales Value Share 2021 VS 2025 VS 2032
Figure 21. Global Digital COPD Management Sales Value Share by Application (2021-2032)
Figure 22. Global Digital COPD Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 23. Global Digital COPD Management Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 24. North America Digital COPD Management Sales Value (2021-2032) & (US$ Million)
Figure 25. North America Digital COPD Management Sales Value Share by Country (%), 2025 VS 2032
Figure 26. Europe Digital COPD Management Sales Value (2021-2032) & (US$ Million)
Figure 27. Europe Digital COPD Management Sales Value Share by Country (%), 2025 VS 2032
Figure 28. Asia-Pacific Digital COPD Management Sales Value (2021-2032) & (US$ Million)
Figure 29. Asia-Pacific Digital COPD Management Sales Value Share by Country (%), 2025 VS 2032
Figure 30. South America Digital COPD Management Sales Value (2021-2032) & (US$ Million)
Figure 31. South America Digital COPD Management Sales Value Share by Country (%), 2025 VS 2032
Figure 32. Middle East & Africa Digital COPD Management Sales Value (2021-2032) & (US$ Million)
Figure 33. Middle East & Africa Digital COPD Management Sales Value Share by Country (%), 2025 VS 2032
Figure 34. USA Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 35. USA Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 36. USA Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 37. Canada Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 38. Canada Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 39. Canada Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 40. Mexico Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. Mexico Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. Mexico Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. Germany Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. Germany Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. Germany Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. France Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. France Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. France Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. U.K. Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. U.K. Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. U.K. Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. Italy Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. Italy Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. Italy Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. Spain Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. Spain Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. Spain Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Russia Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Russia Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Russia Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Netherlands Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Netherlands Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Netherlands Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. Nordic Countries Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. Nordic Countries Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. Nordic Countries Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. China Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. China Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. China Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. Japan Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. Japan Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. Japan Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. South Korea Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. South Korea Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. South Korea Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. India Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. India Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. India Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. Australia Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. Australia Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. Australia Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. Southeast Asia Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. Southeast Asia Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. Southeast Asia Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Brazil Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Brazil Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Brazil Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Argentina Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Argentina Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Argentina Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Chile Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Chile Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Chile Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Colombia Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Colombia Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Colombia Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Peru Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Peru Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Peru Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Saudi Arabia Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Saudi Arabia Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Saudi Arabia Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. Israel Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. Israel Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. Israel Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. UAE Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. UAE Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. UAE Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Turkey Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Turkey Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Turkey Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. Iran Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. Iran Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. Iran Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Egypt Digital COPD Management Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 116. Egypt Digital COPD Management Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 117. Egypt Digital COPD Management Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 118. Years Considered
Figure 119. Research Process
Figure 120. Key Executives Interviewed
Scope & coverage.
Types
- Symptom Monitoring
- Lung Function Management
- Acute Exacerbation Prediction
- Medication Adherence Management
- Others
Applications
- Hospital Respiratory Department Management
- Home Health Self-Management
- Insurance-Based Health Management
- Telemedicine
Companies covered
- Teva Digital Health
- AstraZeneca Digital Health
- GSK Digital Health
- Boehringer Ingelheim Digital Health
- Huma Therapeutics
- Biofourmis
- Kaia Health
- Ada Health
- Current Health
- Wellinks
- Sensviv
- ResMed Inc
- Philips Respironics
- Propeller Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Digital COPD Management Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Digital COPD Management Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Digital COPD Management Market Dynamics
- 2.1 Digital COPD Management Industry Trends
- 2.2 Digital COPD Management Industry Drivers
- 2.3 Digital COPD Management Industry Opportunities and Challenges
- 2.4 Digital COPD Management Industry Restraints
3 Digital COPD Management Market by Company
- 3.1 Global Digital COPD Management Company Revenue Ranking in 2025
- 3.2 Global Digital COPD Management Revenue by Company (2021-2026)
- 3.3 Global Digital COPD Management Company Ranking (2024-2026)
- 3.4 Global Digital COPD Management Company Manufacturing Base and Headquarters
- 3.5 Global Digital COPD Management Company Product Type and Application
- 3.6 Global Digital COPD Management Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Digital COPD Management Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Digital COPD Management Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Digital COPD Management Market by Type
- 4.1 Digital COPD Management Type Introduction
- 4.1.1 Symptom Monitoring
- 4.1.2 Lung Function Management
- 4.1.3 Acute Exacerbation Prediction
- 4.1.4 Medication Adherence Management
- 4.1.5 Others
- 4.2 Global Digital COPD Management Sales Value by Type
- 4.2.1 Global Digital COPD Management Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Digital COPD Management Sales Value by Type (2021-2032)
- 4.2.3 Global Digital COPD Management Sales Value Share by Type (2021-2032)
5 Digital COPD Management Market by Application
- 5.1 Digital COPD Management Application Introduction
- 5.1.1 Hospital Respiratory Department Management
- 5.1.2 Home Health Self-Management
- 5.1.3 Insurance-Based Health Management
- 5.1.4 Telemedicine
- 5.2 Global Digital COPD Management Sales Value by Application
- 5.2.1 Global Digital COPD Management Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Digital COPD Management Sales Value by Application (2021-2032)
- 5.2.3 Global Digital COPD Management Sales Value Share by Application (2021-2032)
6 Digital COPD Management Regional Value Analysis
- 6.1 Global Digital COPD Management Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Digital COPD Management Sales Value by Region (2021-2032)
- 6.2.1 Global Digital COPD Management Sales Value by Region: 2021-2026
- 6.2.2 Global Digital COPD Management Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Digital COPD Management Sales Value (2021-2032)
- 6.3.2 North America Digital COPD Management Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Digital COPD Management Sales Value (2021-2032)
- 6.4.2 Europe Digital COPD Management Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Digital COPD Management Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Digital COPD Management Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Digital COPD Management Sales Value (2021-2032)
- 6.6.2 South America Digital COPD Management Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Digital COPD Management Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Digital COPD Management Sales Value Share by Country, 2025 VS 2032
7 Digital COPD Management Country-level Value Analysis
- 7.1 Global Digital COPD Management Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Digital COPD Management Sales Value by Country (2021-2032)
- 7.2.1 Global Digital COPD Management Sales Value by Country (2021-2026)
- 7.2.2 Global Digital COPD Management Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.7.2 France Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.14.2 China Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.17.2 India Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Digital COPD Management Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Digital COPD Management Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Digital COPD Management Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Digital COPD Management Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Teva Digital Health
- 8.1.1 Teva Digital Health Company Information
- 8.1.2 Teva Digital Health Business Overview
- 8.1.3 Teva Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Digital Health Digital COPD Management Product Portfolio
- 8.1.5 Teva Digital Health Recent Developments
- 8.2 AstraZeneca Digital Health
- 8.2.1 AstraZeneca Digital Health Company Information
- 8.2.2 AstraZeneca Digital Health Business Overview
- 8.2.3 AstraZeneca Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.2.4 AstraZeneca Digital Health Digital COPD Management Product Portfolio
- 8.2.5 AstraZeneca Digital Health Recent Developments
- 8.3 GSK Digital Health
- 8.3.1 GSK Digital Health Company Information
- 8.3.2 GSK Digital Health Business Overview
- 8.3.3 GSK Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.3.4 GSK Digital Health Digital COPD Management Product Portfolio
- 8.3.5 GSK Digital Health Recent Developments
- 8.4 Boehringer Ingelheim Digital Health
- 8.4.1 Boehringer Ingelheim Digital Health Company Information
- 8.4.2 Boehringer Ingelheim Digital Health Business Overview
- 8.4.3 Boehringer Ingelheim Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.4.4 Boehringer Ingelheim Digital Health Digital COPD Management Product Portfolio
- 8.4.5 Boehringer Ingelheim Digital Health Recent Developments
- 8.5 Huma Therapeutics
- 8.5.1 Huma Therapeutics Company Information
- 8.5.2 Huma Therapeutics Business Overview
- 8.5.3 Huma Therapeutics Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.5.4 Huma Therapeutics Digital COPD Management Product Portfolio
- 8.5.5 Huma Therapeutics Recent Developments
- 8.6 Biofourmis
- 8.6.1 Biofourmis Company Information
- 8.6.2 Biofourmis Business Overview
- 8.6.3 Biofourmis Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.6.4 Biofourmis Digital COPD Management Product Portfolio
- 8.6.5 Biofourmis Recent Developments
- 8.7 Kaia Health
- 8.7.1 Kaia Health Company Information
- 8.7.2 Kaia Health Business Overview
- 8.7.3 Kaia Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.7.4 Kaia Health Digital COPD Management Product Portfolio
- 8.7.5 Kaia Health Recent Developments
- 8.8 Ada Health
- 8.8.1 Ada Health Company Information
- 8.8.2 Ada Health Business Overview
- 8.8.3 Ada Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.8.4 Ada Health Digital COPD Management Product Portfolio
- 8.8.5 Ada Health Recent Developments
- 8.9 Current Health
- 8.9.1 Current Health Company Information
- 8.9.2 Current Health Business Overview
- 8.9.3 Current Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.9.4 Current Health Digital COPD Management Product Portfolio
- 8.9.5 Current Health Recent Developments
- 8.10 Wellinks
- 8.10.1 Wellinks Company Information
- 8.10.2 Wellinks Business Overview
- 8.10.3 Wellinks Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.10.4 Wellinks Digital COPD Management Product Portfolio
- 8.10.5 Wellinks Recent Developments
- 8.11 Sensviv
- 8.11.1 Sensviv Company Information
- 8.11.2 Sensviv Business Overview
- 8.11.3 Sensviv Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.11.4 Sensviv Digital COPD Management Product Portfolio
- 8.11.5 Sensviv Recent Developments
- 8.12 ResMed Inc
- 8.12.1 ResMed Inc Company Information
- 8.12.2 ResMed Inc Business Overview
- 8.12.3 ResMed Inc Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.12.4 ResMed Inc Digital COPD Management Product Portfolio
- 8.12.5 ResMed Inc Recent Developments
- 8.13 Philips Respironics
- 8.13.1 Philips Respironics Company Information
- 8.13.2 Philips Respironics Business Overview
- 8.13.3 Philips Respironics Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.13.4 Philips Respironics Digital COPD Management Product Portfolio
- 8.13.5 Philips Respironics Recent Developments
- 8.14 Propeller Health
- 8.14.1 Propeller Health Company Information
- 8.14.2 Propeller Health Business Overview
- 8.14.3 Propeller Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 8.14.4 Propeller Health Digital COPD Management Product Portfolio
- 8.14.5 Propeller Health Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst